13/10/2018
Dr Abhishek Kulkarni, Head: Pediatric & Adolescent Endocrinology T2T Hormone Clinics India spoke on benefits of CSII- Insulin Pump therapy & patient selection criteria with inputs of his unit experience at the Insulin Pump Symposium of the 44th Annual Conference of the International Society of Pediatric & Adolescent Diabetes 2018. ISPAD is the single largest conglomerate of physicians caring for children with all forms of diabetes mellitus globally. The message “ Insulin pump therapy remains the current most physiologic form of insulin replacement therapy for children with insulin dependent diabetes mellitus “ Insulin pump therapy needs on going intense patient & family training mandating the presence of a multidisciplinary team to provide contemporary standards of care. We wish to acknowledge the efforts my entire team of T2T Hormone Clinics India 🇮🇳 & Child Hormone Foundation, Mumbai in addition to paediatricians & parents of children with type 1 DM for the herculean efforts that it takes to provide acceptable contemporary standards of care to them.
